Ifp Advisors, Inc Bio Affinity Technologies, Inc. Transaction History
Ifp Advisors, Inc
- $2.42 Billion
- Q2 2024
A detailed history of Ifp Advisors, Inc transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 10,000 shares of BIAF stock, worth $20,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 5,000
100.0%
Holding current value
$20,600
Previous $10,000
110.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BIAF
# of Institutions
18Shares Held
400KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA172KShares$354,3070.0% of portfolio
-
Geode Capital Management, LLC Boston, MA69.6KShares$143,3760.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$57,4430.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny23KShares$47,3120.0% of portfolio
-
Ground Swell Capital, LLC Folly Beach, SC22.9KShares$47,0990.04% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $5.62M
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...